Sarepta Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Sarepta Therapeutics (NASDAQ:SRPT) has announced its participation in the 41st Annual J.P. Morgan Healthcare Conference on January 9, 2023, at 1:30 p.m. E.T. in San Francisco, California. A Q&A session will follow at 1:50 p.m. E.T. The presentation will be available via live webcast on Sarepta's investor relations website and archived for 90 days thereafter. Sarepta focuses on precision genetic medicine for rare diseases, with over 40 programs in development, particularly in Duchenne muscular dystrophy and limb-girdle muscular dystrophies. For more details, visit their website.

CAMBRIDGE, Mass., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California on Monday, January 9, 2023 at 1:30 p.m. E.T. / 10:30 a.m. P.T. Following the presentation there will be a Q&A session starting at 1:50 p.m. E.T. / 10:50 a.m. P.T.

The presentation will be webcast live under the Events & Presentations section of the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Sarepta Therapeutics
Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information, please visit www.sarepta.com or follow us on Twitter, LinkedIn, Instagram and Facebook.

Internet Posting of Information
We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important information about us.

Source: Sarepta Therapeutics, Inc.

Investor Contact:
Ian Estepan, 617-274-4052
iestepan@sarepta.com

Media Contact:
Tracy Sorrentino, 617-301-8566
tsorrentino@sarepta.com

FAQ

When will Sarepta Therapeutics present at the J.P. Morgan Healthcare Conference?

Sarepta Therapeutics will present on January 9, 2023, at 1:30 p.m. E.T.

Where can I watch the Sarepta Therapeutics presentation live?

The presentation will be webcast live on Sarepta's investor relations website.

What time is the Q&A session following Sarepta's presentation?

The Q&A session will start at 1:50 p.m. E.T. on January 9, 2023.

How long will the Sarepta Therapeutics presentation be available for replay?

The presentation will be archived for 90 days after the live event.

What areas does Sarepta Therapeutics focus on?

Sarepta focuses on precision genetic medicine for rare diseases, including Duchenne muscular dystrophy and limb-girdle muscular dystrophies.